Suren G. Dutia serves as Executive at CITIUS ONCOLOGY, INC., where they oversee executive responsibilities. Since joining the company, Suren G. Dutia has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 19, 2025 involved receiving (via award) 300,000 shares valued at $0.
Suren G. Dutia currently holds 300,000 shares of CITIUS ONCOLOGY, INC. (CTOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suren G. Dutia has been a net neutral trader of CTOR stock. They have purchased $0 and sold $0 worth of shares.
Suren G. Dutia's most recent insider trade was on Sep 19, 2025, when they sold 300,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 19, 2025 | CTOR | $0 | Award | 300,000 | $N/A | Discretionary |